Signature »

Kyverna Therapeutics shares owned by Signature

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Signature from 13F filings

Historical chart of Signature investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Signature

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.2k 466 8.91
2024-09-30 $1.5k 314 4.89

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr National Mun Etf (MUB)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)

View all positions for Signature

Top funds holding Kyverna Therapeutics

Gilead Sciences
BlackRock
Bain Capital Life Sciences Investors
AIGH Capital Management
Deerfield Management Company
Vanguard Capital Management
T. Rowe Price Associates
Geode Capital Management
Insight Holdings
Morgan Stanley
Propel Bio Management
Woodline Partners
Millennium Management
Mbb Public Markets I
Adage Capital Partners GP

View all funds holding Kyverna Therapeutics